Differential responses of normal human coronary artery endothelial cells against multiple cytokines comparatively assessed by gene expression profiles

FEBS Letters

Volumn 580, Issue 30, 2006, Pages 6871-6879

  Miura, Aya ^a,c   Honma, Reiko ^b   Togashi, Takushi ^c   Yanagisawa, Yuka ^b   Ito, Emi ^b   Imai, Jun ichi ^b   Isogai, Takao ^a,d   Goshima, Naoki ^c   Watanabe, Shinya ^b   Nomura, Nobuo ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Japan Biological Information Research Center   (Japan)

^d Reverse Proteomics Research Institute Co Ltd   (Japan)

Author keywords

Cellular response; Cytokine; DNA microarray; Endothelial cell; Gene expression

Indexed keywords

BETA INTERFERON; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 1BETA; ONCOSTATIN M; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; CORONARY ARTERY; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ISOLATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ARTERIES; CELL LINE; COLON; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS;

EID: 33845420833     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.11.041     Document Type: Article

References (32)

1. Cines D.B., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91 (1998) 3527-3561
2. Rodgers G.M. Hemostatic properties of normal and perturbed vascular cells. FASEB J. 2 (1988) 116-123
3. Edgington T.S. Vascular biology: integrative molecular cell biology. FASEB. J. 9 (1995) 841-842
4. Barton M. Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics. Curr. Hypertens. Rep. 2 (2000) 84-91
5. Murakami T., et al. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J. Atheroscler. Thromb. 7 (2000) 39-44
6. Sana T.R., Janatpour M.J., Sathe M., McEvoy L.M., and McClanahan T.K. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29 (2005) 256-269
7. Zhao B., Stavchansky S.A., Bowden R.A., and Bowman P.D. Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. Am. J. Physiol. Cell Physiol. 284 (2003) 1577-1583
8. Eder J. Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all?. Trends Pharmacol. Sci. 18 (1997) 319-322
9. Takaoka A., and Yanai H. Interferon signalling network in innate defence. Cell Microbiol. 8 (2006) 907-922
10. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
11. Ito E., et al. A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor. Am. J. Pathol. 163 (2003) 2165-2172
12. Sakamoto A., et al. Influence of inhalation anesthesia assessed by comprehensive gene expression profiling. Gene 356 (2005) 39-48
13. Mantovani A., Garlanda C., Introna M., and Vecchi A. Regulation of endothelial cell function by pro- and anti-inflammatory cytokines. Transplant. Proc. 30 (1998) 4239-4243
14. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
15. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55 (2001) 255-281
16. Brown T.J., Rowe J.M., Liu J.W., and Shoyab M. Regulation of IL-6 expression by oncostatin M. J. Immunol. 147 (1991) 2175-2180
17. Modur V., Feldhaus M.J., Weyrich A.S., Jicha D.L., Prescott S.M., Zimmerman G.A., and McIntyre T.M. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J. Clin. Invest. 100 (1997) 158-168
18. Wahl A.F., and Wallace P.M. Oncostatin M in the anti-inflammatory response. Ann. Rheum. Dis. 60 (2001) 75-80
19. Vasse M., Pourtau J., Trochon V., Muraine M., Vannier J.P., Lu H., Soria J., and Soria C. Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1835-1842
20. Dinarello C.A., Gelfand J.A., and Wolff S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269 (1993) 1829-1835
21. Sen G.C., and Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267 (1992) 5017-5020
22. Peri S., et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 13 (2003) 2363-2371
23. Briones M.A., Phillips D.J., Renshaw M.A., and Hooper W.C. Expression of chemokine by human coronary-artery and umbilical-vein endothelial cells and its regulation by inflammatory cytokines. Coron Artery Dis. 12 (2001) 179-186
24. Krishnaswamy G., Smith J.K., Mukkamala R., Hall K., Joyner W., Yerra L., and Chi D.S. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids. Microvasc Res. 55 (1998) 189-200
25. Harlan J.M. Leukocyte-endothelial interactions. Blood 65 (1985) 513-525
26. Breslin J.W., Pappas P.J., Cerveira J.J., Hobson II R.W., and Duran W.N. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) 92-100
27. Takahashi H., Numasaki M., Lotze M.T., and Sasaki H. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol. Lett. 98 (2005) 189-193
28. Chen J., Li D., Zhang X., and Mehta J.L. Tumor necrosis factor-alpha-induced apoptosis of human coronary artery endothelial cells: modulation by the peroxisome proliferator-activated receptor-gamma ligand pioglitazone. J. Cardiovasc. Pharmacol. Ther. 9 (2004) 35-41
29. Dauphinee S.M., and Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 86 (2006) 9-22
30. Passerini A.G., Milsted A., and Rittgers S.E. Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J. Vasc. Surg. 37 (2003) 182-190
31. Risberg B., Andreasson S., and Eriksson E. Disseminated intravascular coagulation. Acta. Anaesthesiol. Scand. Suppl. 95 (1991) 60-71
32. Le A.Q., Duval D., and Tobelem G. Tumour angiogenesis. Baillieres Clin. Haematol. 6 (1993) 711-730